✦ LIBER ✦

PCN35 COST-EFFECTIVENESS ANALYSIS OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT OR INTOLERANT CML PATIENTS IN BRAZIL

✍ Scribed by C Ouissak; G Litalien; MR Alves

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN13 Cost-Effectiveness Analysis of Nil

✍ Niu, X.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN34 BUDGET IMPACT ANALYSIS OF DASATINI

✍ E Asano; M Nita; A Moellmann-Coelho; R Rached; B Donato; E Rahal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN14 THE COST AND COST EFFECTIVENESS OF

✍ Juarez-Garcia, A; Uc-Coyoc, R; Hernandez-Rivera, G; Rangel, S; Taylor, MJ; Lital 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PSY17 THE COST AND COST EFFECTIVENESS OF

✍ A Juarez-Garcia; L Zapata; G Vega; J Idrovo; R Rivas; JL Kramis; G Litalien; S R 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCN69 COST-EFFECTIVENESS ANALYSIS OF DAS

✍ de Ramirez; A Arellano; U Sbarigia; MJ Taylor; P Martin; G Restovic 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PCN124 COST-UTILITY ANALYSIS OF DASATINI

✍ E Asano; M Nita; A Moellmann-Coelho; R Rached; B Donato; E Rahal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB